Previous Article | Next Article 
Infection and Immunity, March 2001, p. 1729-1738, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1729-1738.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification and Characterization of a Second
Extracellular Collagen-Like Protein Made by Group A
Streptococcus: Control of Production at the Level
of Translation
Slawomir
Lukomski,1
Kazumitsu
Nakashima,1,
Iman
Abdi,1
Vincent J.
Cipriano,1
Bobby J.
Shelvin,1
Edward A.
Graviss,1 and
James M.
Musser1,2,*
Department of Pathology, Baylor College of
Medicine, Houston, Texas 77030,1 and
Laboratory of Human Bacterial Pathogenesis, Rocky Mountain
Laboratories, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, Hamilton, Montana
598402
Received 31 October 2000/Returned for modification 27 November
2000/Accepted 29 November 2000
 |
ABSTRACT |
A recent study found that group A Streptococcus (GAS)
expresses a cell surface protein with similarity to human collagen (S. Lukomski, K. Nakashima, I. Abdi, V. J. Cipriano, R. M. Ireland, S. R. Reid, G. G. Adams, and J. M. Musser,
Infect. Immun. 68:6542-6553, 2000). This streptococcal collagen-like
protein (Scl) contains a long region of Gly-X-X motifs and was produced
by serotype M1 GAS strains. In the present study, a second member of
the scl gene family was identified and designated
scl2. The Scl2 protein also has a collagen-like region,
which in M1 strains is composed of 38 contiguous Gly-X-X triplet
motifs. The scl2 gene was present in all 50 genetically
diverse GAS strains studied. The Scl2 protein is highly polymorphic,
and the number of Gly-X-X motifs in the 50 strains studied ranged from
31 in one serotype M1 strain to 79 in serotype M28 and M77 isolates.
The scl1 and scl2 genes were simultaneously
transcribed in the exponential phase, and the Scl proteins were also
produced. Scl1 and Scl2 were identified in a cell-associated form and
free in culture supernatants. Production of Scl1 is regulated
by Mga, a positive transcriptional regulator that controls expression
of several GAS virulence factors. In contrast, production of Scl2 is
controlled at the level of translation by variation in the number of
short-sequence pentanucleotide repeats (CAAAA) located immediately
downstream of the GTG (Val) start codon. Control of protein production
by this molecular mechanism has not been identified previously in GAS.
Together, the data indicate that GAS simultaneously produces two
extracellular human collagen-like proteins in a regulated fashion.
 |
INTRODUCTION |
Group A Streptococcus
(GAS) causes human infections of the throat and soft tissue and
systemic diseases (39). This broad spectrum of infected
tissues indicates that GAS can adapt to changing environments during
pathogen-host interactions. In addition, the wide range of infections
caused by GAS suggests that virulence factor expression is a very
complex regulated process. Indeed, transcriptional and
posttranscriptional mechanisms that control expression of virulence
genes have been described (1, 9, 17, 21, 31). For example,
several streptococcal cell surface proteins expressed in exponential
growth are regulated by Mga, a positive transcriptional activator
protein (3, 23, 27, 32).
Microbial extracellular molecules interact with host proteins and often
mediate adherence (26). Several cell surface proteins of
gram-positive bacteria have structural similarities that include a
variable amino terminus, a central region composed of repeating units,
and a carboxy-terminal cell-associated region with an LPXTG cell wall
anchor motif (8). GAS cell surface proteins have been
identified as proven or potential virulence factors and include M
protein (7), immunoglobulin (14) and
fibronectin (13) binding proteins, serum opacity factor
(4), C5a peptidase (44), and GRAB
(34).
Recently, we identified a new GAS cell surface protein that contains a
central region composed of variable numbers of Gly-X-X (GXX)
collagen-like motifs (20). The gene (scl)
encoding this streptococcal collagen-like (Scl) protein was present
in all 50 GAS strains studied and was preferentially transcribed in the logarithmic phase of growth by a serotype M1 GAS strain. Although the
exact role of Scl in human pathogenesis is not understood, an isogenic
scl mutant had decreased adherence to human fibroblasts grown in culture and was attenuated for virulence in mice, as assessed
by subcutaneous inoculation (20).
In this study, we characterized a second gene (scl2)
encoding a collagen-like protein. The scl2 gene also was
present in all 50 genetically diverse strains studied, together
representing 21 distinct M protein serotypes. Expression of
scl1 is controlled transcriptionally by Mga. In contrast,
production of Scl2 is controlled at the level of translation by the
number of CAAAA pentanucleotide repeats located immediately
downstream from a GTG (Val) start codon. This form of regulation
has not been described in GAS or other gram-positive pathogens.
 |
MATERIALS AND METHODS |
Bacterial strains and growth.
Fifty GAS strains isolated
worldwide were used. The strain collection was described in a recent
analysis of the molecular population genetics and virulence role of
Scl1 (20). The 50 GAS strains represented 21 different M
types, as verified by sequencing the emm gene fragment
encoding the hypervariable amino terminus. MGAS6708 is identical to
SF370, the serotype M1 strain used in a genome sequencing project
(http://www.genome.ou.edu/strep.html). Isogenic M1 GAS strains
JRS301 (wild type) and JRS403 (mga mutant) (28)
were kindly provided by June R. Scott (Emory University).
GAS strains were grown at 37°C in 5% CO2-20%
O2 in Todd-Hewitt broth (Difco Laboratories, Detroit,
Mich.) supplemented with 0.2% yeast extract (THY medium) or on
tryptose agar with 5% sheep blood (Becton Dickinson, Cockeysville,
Md.).
Cloning experiments were performed with
Escherichia coli
XL-1 Blue (Stratagene, La Jolla, Calif.) grown in Luria-Bertani media
(Difco Laboratories).
E. coli TB1 (New England Biolabs,
Inc.,
Beverly, Mass.) was used for experiments with
scl2-phoZ fusions.
Construction of scl2-phoZ fusions.
Plasmid
pDC123 (obtained from C. E. Rubens, University of Washington) and
the scl2 genes from MGAS5005 (serotype M1) and MGAS6274 (serotype M28) were used. Shuttle vector pDC123 (2)
contains the phoZ gene (16) transcribed from
constitutively expressed tetM and cat tandem
promoters. The phoZ gene present in pDC123 confers a
blue-colony phenotype to E. coli and GAS grown on media supplemented with 5-bromo-4-chloro-3-indolylphosphate (XP or BCIP) (2). Intracellular alkaline phosphatase (AP) activity was
minimal or negligible but increased substantially when AP was secreted, indicating that abundant AP activity was export dependent.
Plasmid pDC123 was digested with restriction endonucleases
Eco47III and
SphI, which flank the DNA fragment
containing the
phoZ gene Shine-Dalgarno box, signal
sequence, and multiple cloning
site located at the 5' end of
phoZ. The entire promoter region
and the complete signal
sequence of the
scl2 gene were amplified
with primers
scl2-SmaI and scl2-SphI from MGAS5005 (serotype M1)
and MGAS6274
(serotype M28). These PCR fragments were cleaved
with
SmaI
and
SphI and directionally cloned between the
Eco47III
and
SphI sites of digested pDC123. The
new plasmids contained
the
phoZ structural gene fused to the
5' region of
scl2 that encodes
the Scl2 signal sequence.
These
scl2-phoZ constructs also contain
the
scl2
promoter
region.
DNA methods.
Standard molecular-biology techniques were used
(36). Plasmid DNA was purified with the UltraClean kit (Mo
Bio Laboratories, Inc., Solana Beach, Calif.). GAS chromosomal DNA was
isolated as described previously (25). The presence of the
scl2 gene in GAS strains was assessed by PCR. The entire
scl2 open reading frame (ORF) was amplified with forward
primer scl2-up (5'-CTTTCAATGGATGACGATACC; nucleotides
29
to
9 upstream of the sequence shown in Fig.
1) and reverse primer scl2-rev
(5'-ACTTTCCATCAGTTAGGTAGC; nucleotide positions 1160 to 1140 in Fig. 1) using Taq polymerase (Life Technologies). DNA was
denatured at 94°C for 1 min. Thirty amplification cycles were
performed as follows: 1 min of denaturation at 94°C, 1 min of
annealing at 55°C, and 1 min 45 s of extension at 72°C,
followed by one cycle of 5 min at 72°C. The PCR products were
analyzed by agarose gel electrophoresis and sequenced with internal
primers and the Taq DyeDeoxy terminator cycle sequencing kit
(Applied Biosystems, Inc., Foster City, Calif.) with an ABI 377 instrument. The DNA sequence data were analyzed with Sequencher,
version 3.1.1 (Gene Codes Corporation, Inc., Ann Arbor, Mich.) and
Lasergene (DNASTAR, Inc., Madison, Wis.) software.

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 1.
Nucleotide and amino acid sequences of the
scl2 gene and inferred Scl2 protein in serotype M1 GAS
(MGAS6708). The scl2 ORF consists of 951 bp (nucleotides 178 to 1129). The presumed scl promoter region has a predicted
ribosome-binding site (RBS) and 10 and 35 regions. Dot at +1
inferred transcription start site. A potential transcription terminator
(tt) consisting of two inverted repeats is located
downstream of the ORF. The predicted GTG start codon (Val) and the TAA
stop codon are in boldface. The inferred mature Scl2 polypeptide
consists of 281 amino acids (nucleotides 284 to 1126). Four SSRs
(CAAAA) located immediately after the GTG start codon would cause a
frameshift in the downstream scl2 gene and result in
premature termination of translation. SS, signal sequence; V, variable
region; CL, collagen-like region consisting of 38 Gly-X-X triplet
motifs (boxed); WM, cell wall membrane region containing the LPATG cell
wall anchor motif (shaded). A T C point mutation (dot) in the TAA
stop codon of the scl2 gene was present in all serotype M3
GAS strains. This polymorphism would extend the inferred Scl2 protein
by 11 amino acid residues (italicized protein sequence between
stars).
|
|
RNA methods.
GAS strains were grown in THY medium and total
RNA was isolated as described previously (19). Bacteria
from 10-ml cultures were harvested and resuspended in Tris-EDTA buffer
(10 mM Tris [pH 7.0], 1 mM EDTA). Cells were treated at 37°C for 5 min with mutanolysin (25 U) and lysozyme (1 mg/ml) in the presence of a 5 mM concentration of RNase inhibitor aurintricarboxylic acid. The
cells were lysed by adding sodium dodecyl sulfate (SDS) (2% final
concentration) and an equal volume of acid-phenol-chloroform at 65°C
for 5 min. The samples were extracted with acid-phenol-chloroform, and
RNA was precipitated with 2 volumes of ethanol in the presence of 0.2 M
NaCl. DNA contamination was removed by digestion with DNase I, and the
RNA was precipitated as described above.
For Northern analyses, 10 µg of total RNA was transferred onto a
positively charged nylon membrane (Tropilon-Plus; Tropix,
Bedford,
Mass.). DNA probes were amplified by PCR using GAS genomic
DNAs as
templates. Since both
scl1 and
scl2 genes were
present
in GAS, the DNA probes were designed to avoid
cross-hybridization
in Northern blots. The DNA probes were amplified
from the homologous
GAS strains with the following primers:
scl1 probe, 5'-GGCAAGCAGCGTTAAGGCTGA
(forward)
and 5'-TATGAAGACCTGCGCTTTGGTTAGCTTCTTTGTCAGCAGG (reverse);
scl2 probe, 5'-TGCTGACCTTTGGAGGTGC (forward) and
5'-CGCCTGTTGCTGGCAATTGTC
(reverse). The probes were
biotinylated with BrightStar labeling
reagents, and hybridization was
performed with NorthernMax reagents
(Ambion, Austin, Tex.). The
hybridization signal was visualized
with a chemiluminescence kit
(Southern-Star; Tropix). Transcript
sizes were estimated with RNA size
markers (Life
Technologies).
Protein methods.
The presence of the Scl1 and Scl2 proteins
in culture supernatants and streptococcal cell wall fractions was
studied. GAS strains were grown to exponential phase (optical density
at 600 nm [OD600] of ~0.5) in 150 ml of THY medium and
pelleted by centrifugation, and total proteins in the culture
supernatants were obtained by precipitation with trichloroacetic acid
(TCA; 10% final concentration) on ice for 1 h. The
TCA-precipitated protein samples were neutralized with saturated Tris
before being loaded on an SDS-12% polyacrylamide gel electrophoresis
(PAGE) gel. The cell wall-associated protein fractions were obtained
from GAS cells resuspended in 2 ml of 20% sucrose with 10 mM Tris, pH
8.0, buffer containing 25 U of mutanolysin and 1 mg of lysozyme/ml.
Cells were digested at 37°C for 1 h and pelleted by
centrifugation, and the supernatants containing the cell wall fraction
were used for subsequent analyses.
Rabbit polyclonal sera specific for Scl1 or Scl2 proteins made by
several M serotype GAS strains were generated (Bethyl Laboratories,
Inc., Montgomery, Tex.). The following synthetic peptides were
used to
raise an anti-Scl1-specific antibody: M1 GAS, TTMTSSQRESKIKEI;
M28, FWGRRYFNEQEYLKS; and M52, VYQKEVEQYTKEAL.
Peptides EENEKVREQEKLIQQ
(serotype M1) and
KLLTYLQEREQAENSW (serotype M28) were used to
obtain
anti-Scl2-specific sera. These peptide sequences corresponded
to amino
acid residues located in the amino-terminal (variable
[V]) regions of
mature Scl1 and Scl2 proteins. The peptides were
designed to maximize
antigenic and surface probability indices
and minimize or avoid
cross-reactivity. All immune rabbit sera
had reactivity against the
corresponding peptides in enzyme-linked
immunosorbent assays, whereas
preimmune sera from the same rabbits
did not (data not
shown).
Scl1 and Scl2 protein production and secretion by wild-type GAS strains
were assessed by Western blot analysis. Protein samples
obtained from
the culture supernatants and from the cell wall
fractions were
separated by SDS-12% PAGE and transferred to a
nitrocellulose
membrane (Hybond ECL; Amersham Pharmacia Biotech,
Piscataway, N.J.).
Immunodetection of Scl was performed with specific
rabbit antisera
(1:500 dilution). Each Western blot was probed
in parallel with both
preimmune and immune sera to evaluate background
reactivity.
Horseradish peroxidase-conjugated goat anti-rabbit
affinity-purified
immunoglobulin G (heavy and light chains) (Bio-Rad,
Hercules, Calif.)
was used as the secondary antibody, and detection
was done with
chemiluminescence ECL reagents (Amersham Pharmacia
Biotech). Prestained
broad-range marker proteins (Bio-Rad) were
used as molecular mass
standards.
Nucleotide sequence accession number.
The scl2
sequence data reported here have been deposited in GenBank under
accession no. AF317835.
 |
RESULTS |
Identification and analysis of the scl2 gene and
inferred Scl2 protein in serotype M1 GAS.
We recently described a
GAS gene encoding a presumed cell-associated protein with a long region
of Gly-X-X repeats (20). The protein was named Scl for
streptococcal collagen-like, and the gene was designated
scl. The protein sequence corresponding to the hydrophobic
cell membrane domain of cell surface protein M6
(FFTAAALTVMATAGVAAVV) (7) was used as the
search query. With the exception of a small part of the scl
gene sequence with similarity to the emm6 gene sequence
encoding the carboxy-terminal transmembrane domain, there was no
homology between scl and other GAS genes encoding cell
surface proteins. This result suggested that Scl represented a new
class of GAS extracellular protein. Therefore, the M1 genome database
was searched again with protein sequences corresponding to the signal
peptide (amino-terminal 37 amino acids) and cell wall region
(carboxy-terminal 82 amino acids) of Scl (20). One highly
homologous region was identified for each query. The regions of
homology were located 1 kb apart on the opposite side of the GAS
chromosome relative to the location of the scl gene.
Analysis of this region of the GAS chromosome identified a second gene
encoding a collagen-like protein with a long region of Gly-X-X repeats.
To avoid confusion, the original gene was renamed scl1 and
the new gene was designated scl2.
The
scl2 ORF is 951 bp long (nucleotides 178 to 1129) (Fig.
1). A potential promoter located upstream of this ORF includes
a

10
region (TATAAT; perfect match of the consensus sequence)
and
a

35 region (
TTT
ACA; five of six
bases [boldface]
identical to the consensus sequence
TTG
ACA) (
35).
A potential
ribosome-binding site (A
AAA
GAGG; the
consensus sequence is T
AAG
GAGG) is
located 11 nucleotides
upstream from a putative GTG (Val) start codon
(
11,
37). The
putative
scl2 gene would encode a
signal sequence (ss; nucleotides
178 to 283), a variable region
(nucleotides 284 to 484), a collagen-like
region containing Gly-X-X
motifs (CL; nucleotides 485 to 826),
and a cell wall and cell membrane
region containing an LPATG cell
wall anchor motif (WM; nucleotides 827 to 1129). The presumed
GTG (Val) start codon was out of frame with DNA
located immediately
downstream. Four CAAAA nucleotide sequence repeats
were identified
between the presumed GTG start codon and a CAT
(histidine) codon
adjacent to the CAAAA repeat region. The inferred
amino terminus
of Scl2 has structural features characteristic of signal
sequences,
including a short amino-terminal hydrophilic region followed
by
a hydrophobic transmembrane segment and a small amino acid residue
at the cleavage site (
29). Control of gene expression by
short-sequence
nucleotide repeats (SSRs) is well documented in
gram-negative
bacteria (
40). Hence, Scl2 production could
be controlled at
the translation level by variation in the number of
CAAAA
repeats.
The predicted molecular mass of the mature Scl2 protein (residues 1 to
281) is ~29.4 kDa, and the predicted isoelectric point
is 6.22. Except for the hydrophobic transmembrane domain at the
C terminus, the
inferred mature Scl2 protein is hydrophilic (
15).
The
variable region (residues 1 to 67) has a predicted

-helical
structure, whereas the CL region (residues 68 to 181) has a predicted
coiled structure (
10).
Distribution and variation of the scl2 gene among GAS
strains.
The scl2 gene was amplified from strain
MGAS6708 (identical to strain SF370 used for a streptococcal genome
sequencing project) and was sequenced to verify the available genome
data. The scl2 gene was present in all 50 GAS strains
representing the breadth of species genetic diversity as assessed by
multilocus enzyme electrophoresis (24). The size of the
scl2 gene varied among strains representing different M
serotypes. In addition, size variation in the scl2 gene was
common among GAS strains with the same M serotype. This observation
suggested that variation in the scl2 gene exceeded that
found in the scl1 gene. For example, no scl1
sequence variation among serotype M3 GAS strains was identified (20), whereas the scl2 gene varied in size for
all five M3 strains. Hence, the scl2 gene was commonly found
in GAS and was polymorphic in size.
The entire
scl2 gene was sequenced in 25 GAS strains
expressing 13 M types to determine the nature and extent of allelic
variation
(Table
1). The signal sequence
region of the
scl2 gene was conserved
among diverse GAS
strains. The 28 carboxy-terminal amino acids
of the presumed Scl2
protein signal sequence (nucleotides 203
to 283) were 64% identical
and 86% homologous in Scl1 and Scl2
proteins. The V regions were
different in GAS strains representing
different M serotypes; however,
they were identical in strains
of a particular M serotype. Hence, the V
regions in both Scl1
and Scl2 are M type specific. The length of the V
region in Scl2
varied from 61 amino acids in a serotype M9 strain to 77 residues
found in M3 GAS. As identified for Scl1, the CL region of Scl2
was located C terminal to the V region. It contained a variable
number
of Gly-X-X motifs ranging from 33 triplet repeats in an
M1 strain
(MGAS252) to 116 in an M3 serotype GAS strain. The carboxy-terminal
part of Scl2 (WM region) contained 100 amino acid residues that
were
well conserved among all 25 strains characterized. The 38
amino acid
residues at the carboxy terminus of the WM region,
encompassing the
LPATG cell wall anchor motif and the hydrophobic
transmembrane domain,
were 82% identical and 92% homologous in
Scl1 and Scl2. Of note, only
serotype M3 GAS had a single nucleotide
T

C substitution within a TAA
stop codon, potentially creating
an Scl2 variant extended by 11 amino
acid residues (Fig.
1).
Two aspects of the
scl2 gene sequence were of particular
interest: (i) variation in the number of CAAAA pentanucleotide repeats
located immediately downstream from the presumed GTG start codon
with
respect to the coding frame of the downstream sequence and
(ii) the
lack of a nucleotide sequence that would encode a region
analogous to
the linker region encoded by the
scl1 gene. The number
of
CAAAA repeats varied greatly among the GAS strains studied,
ranging
from two in MGAS6191 (M77) to 17 in MGAS6159 (M9) and
MGAS6146 (M56).
Two CAAAA repeats is the minimal number that would
permit correct
translation of Scl2. Similarly, the addition of
three CAAAA repeats
(total of five) or multiples of three repeats
(
n = 8,
11, 14, or 17 repeats, etc.) should result in in-frame
and full-length
Scl2 protein translation. Three contiguous CAAAA
nucleotide repeats
would encode the pentapeptide QNKTK, whereas
other numbers of CAAAA
repeats should cause premature translation
termination.
scl1 gene transcription and Scl production.
We
reported recently that the scl1 gene was transcribed in two
genetically distinct serotype M1 GAS strains (MGAS6708 and MGAS5005). Moreover, the Scl1 protein was present in cell wall fractions prepared from these isolates (20). To
determine if the scl1 gene was transcribed by strains of GAS
representing more than one M protein serotype, we studied three M28
strains (MGAS6141, MGAS6143, and MGAS6274) and an M52 strain
(MGAS6186) by Northern blot analysis (Fig.
2A). The M28 strains were used because
they had three distinct scl1 alleles. Total RNA was isolated
from bacteria grown to logarithmic phase (OD600, ~0.5), a
time when the scl1 gene was abundantly transcribed in M1
strains (20). A single transcript was made by all strains
studied, and the length of each transcript corresponded to the
predicted size obtained from the gene sequence.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 2.
scl1 gene expression in GAS. (A) Northern
blot analysis of total RNA isolated from cultures of GAS serotype M1,
M28, and M52 strains in the logarithmic (OD600, ~0.5)
phase of growth. Total RNA (10 µg) was hybridized with biotinylated
DNA probes amplified by PCR from the corresponding source strains. The
blot was developed with streptavidin-AP conjugate, and the hybridizing
bands were visualized by chemiluminescence. Single scl1 gene
transcripts of the predicted sizes were made by all strains analyzed.
RNA size markers were used to estimate the sizes of the scl1
transcripts. (B) Western blot analysis of the supernatant (S) and cell
wall (W) protein samples prepared from exponential GAS cultures.
Different scl1 gene alleles were translated into Scl1
protein variants. Immunoreactive bands were identified in the cell-free
and cell-associated protein fractions in all strains tested. The Scl1
proteins migrated aberrantly slowly in SDS-PAGE gel. Molecular mass
standards are shown.
|
|
We next determined if the Scl1 protein was produced by these M28 and
M52 strains. Previously, the presence of the Scl1 protein
in the cell
wall-associated fraction was confirmed by analysis
of two M1 GAS
strains harvested in the exponential phase of growth
(
20).
However, extracellular GAS proteins with the LPXTG cell
wall anchor
motif can also be present in the culture media (
8).
Rabbit
antisera specific for the V regions of M28 and M52 strains
were used.
One predominant immunoreactive band was detected by
Western blotting in
each GAS strain (Fig.
2B). A weakly reactive
band of ~60 kDa was
present in M28 GAS. This cross-reacting secreted
product was most
likely not related to Scl1 because it had the
same size in all samples
and was found in the culture supernatants
only. The Scl1 protein was
present in both the cell wall fraction
and cell-free secreted
(supernatant) form. As expected, the size
of the Scl1 protein variant
differed for each GAS strain. All
Scl1 protein variants migrated
aberrantly slowly in SDS-PAGE gels,
a result confirming previous
observations (
20). Together, these
results indicated that
diverse
scl1 alleles were translated into
the Scl1
protein.
Transcription of the scl2 gene by GAS strains.
Sequence analysis (Fig. 1) identified a presumed promoter region
upstream of the scl2 gene and a potential transcription
terminator with two inverted repeats ~40 bp downstream of a TAA stop
codon, suggesting that the scl2 gene encoded a monocistronic
mRNA. Many streptococcal genes are temporally expressed during growth,
including scl1. Therefore, transcription of the
scl2 gene was studied with RNA samples extracted from GAS
cells harvested in exponential (OD600, ~0.5) and
stationary (OD600, ~0.9) phases. Two controls were
included to test the stringency of hybridization with the scl1- and scl2-specific probes. First, MGAS321
was included on the basis of DNA sequence data predicting that the
scl2 gene transcript would be more than 200 bp shorter than
the mRNA for the scl1 gene. Therefore, we assumed that
hybridizing bands would be easily resolved by electrophoresis. Second,
an isogenic MGAS5005 scl mutant (20) was
included as a negative control for the presence of the
scl1-specific transcript.
The
scl1 and
scl2 genes were transcribed
simultaneously in the logarithmic phase by MGAS5005 (M1) (Fig.
3). The
scl2 gene
produced a
monocistronic transcript that was ~100 bp shorter than
the
scl1 transcript. The
scl2 mRNA was made by
MGAS5005 and its
scl1 isogenic mutant (MGAS5005
scl). In contrast, the
scl1 gene
transcript was
detected only in wild-type strain MGAS5005. MGAS321
(M4) also expressed
both
scl genes simultaneously and only during
exponential
growth. The transcript sizes corresponded to the predicted
lengths
based on DNA sequence analysis of the genes. The three
serotype M28
strains studied also simultaneously transcribed
scl1 and
scl2 in the logarithmic phase. In summary, Northern blot
analyses
showed that both
scl genes were transcribed in the
exponential
phase by genetically unrelated GAS strains. No evidence
that gene
transcription occurred in the stationary phase was obtained.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 3.
Transcription of the scl2 gene in GAS. (A)
Northern blot analysis of the total RNA isolated from cultures of GAS
serotype M1, M4, and M28 strains in the logarithmic (L;
OD600, ~0.5) or stationary (S; OD600, ~0.9)
phase of growth. Ten micrograms of total RNA was hybridized with
biotinylated DNA probes prepared from the corresponding source strains
by PCR. Hybridization was identified with streptavidin-AP conjugate
with a chemiluminescence detection method. The scl2 gene
was transcribed by all GAS strains in the exponential phase. RNA size
markers were used to estimate the sizes of the scl2
transcripts.
|
|
Transcription of scl1 is regulated by
mga.
Several GAS cell surface proteins expressed in
exponential growth are regulated by Mga, a positive transcriptional
activator protein (1, 3, 30). The scl1 gene
promoter region has a potential Mga binding site (20). To
directly test the hypothesis that transcription of scl1 is
regulated by Mga, we used an isogenic M1 mutant strain in which
mga had been insertionally inactivated (28).
Northern blot analysis showed that an scl1 transcript was
made by wild-type strain JRS301 but not by the isogenic mutant strain,
JRS403 (Fig. 4). No difference between
early- and mid-logarithmic-phase cultures was identified. In contrast,
an scl2 transcript was made by the wild-type and mutant
organisms, a result indicating that this gene is not regulated by Mga.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 4.
Control of scl1 gene expression by Mga. The
effect of inactivation of the mga gene on transcription of
scl1 and scl2 was studied. Shown is a Northern
blot analysis of the total RNA isolated during the early
(OD600, ~0.3) and middle (OD600, ~0.4)
logarithmic phases of growth from wild-type strain JRS301 and the
isogenic mga mutant, JRS403. scl1 and control
emm1 genes were transcribed in an mga-dependent
fashion. In contrast, transcription of scl2 and the control
gene recA did not require a functional mga
gene.
|
|
Scl2 protein production is controlled by the number of CAAAA
nucleotide repeats.
The sequence of the scl2 gene in
serotype M1 GAS strains indicated that the full-length Scl2 protein
would not be produced due to premature translation termination. We also
observed that the number of CAAAA pentanucleotide repeats located next
to the presumed GTG start codon varied among the 25 GAS strains
sequenced for scl2 (Table 1). In principle, variation in the
number of these repeats would either permit full-length translation of
the scl2 transcript or cause premature termination. Control
of gene expression at the level of translation by variation in the
number of SSRs has been reported for many gram-negative bacterial
species (40), but this mechanism of gene regulation has
not been described for GAS or gram-positive organisms.
Western blot analysis with antibodies raised against synthetic
peptides specific for the V region of Scl2 was used to test
if protein
production was associated with the number of CAAAA
nucleotide repeats
(Fig.
5). All M28 strains
transcribed the
scl2 gene. Supernatant and cell wall
protein fractions were prepared
from bacteria grown to the
logarithmic phase. Scl1 was present
in these protein fractions (Fig.
2B). Two M28 strains, MGAS6143
containing 11 CAAAA repeats and
MGAS6274 with 3 CAAAA repeats
(1 of the CAAAA repeats in this strain is
longer by 1 bp, CAAAAA,
and therefore 3 repeats in this
strain do not cause the frameshift),
were expected to produce Scl2. In
contrast, MGAS6141 (16 CAAAA
repeats) and MGAS6180 (10 CAAAA
repeats) should not produce the
Scl2 protein due to premature
translation termination (Fig.
5A).
Protein samples prepared from
MGAS6143 and MGAS6274 had single
immunoreactive bands (Fig.
5B).
In contrast, only background immunoreactivity
was detected in
the protein samples obtained from MGAS6141 and
MGAS6180. A
similar background level of immunoreactivity was observed
when
preimmune rabbit serum was used (data not shown). Protein
samples
prepared from MGAS5005 contained positive immunoreactivity
for the
anti-Scl1 serum (Fig.
2B). As expected, the same protein
samples did
not contain material that reacted with the anti-Scl2
serum (data not
shown). A positive control was not available for
M1 strains because
none was expected to produce Scl2 on the basis
of DNA sequence data.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 5.
Scl2 protein production depends on the number of
CAAAA pentanucleotide repeats. (A) Schematic of the
scl2 gene GTG start codon and CAAAA repeat region in four
serotype M28 strains. The scl2 genes in MGAS6141 and
MGAS6180 have 16 and 10 CAAAA nucleotide repeats, respectively,
resulting in early translation termination. In contrast,
scl2 genes in MGAS6143 and MGAS6274 have 11 and 3 CAAAA
repeats, respectively, and should produce the extracellular Scl2
protein. Star, stop codon. (B) Immunoblot analysis showing the presence
of Scl2 in the supernatant (S) and cell wall (W) protein samples
obtained from the logarithmic GAS cultures. As anticipated, the Scl2
proteins were identified in cell-free and cell-associated fractions
prepared from MGAS6143 and MGAS6274. Molecular mass standards are
shown.
|
|
To further investigate the involvement of the CAAAA nucleotide repeats
in translational control of Scl2 production, a reporter
system
employing the
Enterococcus faecalis phoZ gene was used.
Secreted, but not intracellular, PhoZ protein has AP activity
and
produces a blue-colony phenotype on media containing XP (see
Material
and Methods). This reporter system (
2,
16) was used
because (i) it was present in pDC123, an
E. coli-GAS shuttle vector,
(ii) it conferred a blue-white-colony
phenotype in both bacterial
species, and (iii) the PhoZ signal sequence
could be replaced
with the signal sequence from C5a peptidase (an
extracellular
GAS protein) without loss of the AP activity, indicating
that
the reporter system functions in
GAS.
The
phoZ signal sequence was replaced with part of the
scl2 gene encoding the promoter region and signal sequence
(Fig.
6A).
Constructs were made with
scl2 fragments obtained from either
MGAS5005
(
scl25005-
phoZ) or MGAS6274
(
scl26274-
phoZ). The
scl2 gene in the
former strain had four CAAAA pentanucleotide repeats,
presumably
responsible for early translation termination of the
Scl2 protein
(Table
1). In contrast, the
scl2 gene present in
the latter
strain had three CAAAA repeats and the full-length
Scl2 protein
was made (Fig.
5). As predicted only
E. coli and
GAS
containing pDC123::
scl26274-
phoZ had a
blue-colony phenotype,
whereas colonies with
pDC123::
scl25005-
phoZ were white on
medium
with XP (Fig.
6B). This important observation indicated that
lack
of Scl2 protein production by MGAS5005 was caused by the
scl2 gene sequence, not by the genetic background of
the host strain.
Hence, export-dependent AP activity occurred
only when the correct
(in-frame) number of CAAAA nucleotide
repeats was located 5' to
the
phoZ gene. Taken together, the
comparative sequence data,
immunoblot analyses, and
scl2-phoZ reporter studies strongly suggest
that Scl2
protein production is regulated at the level of translation
by
variation in the number of CAAAA pentanucleotide repeats located
immediately downstream of the GTG (Val) start codon, in the region
of
the
scl2 gene that encodes the Scl2 signal sequence.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 6.
Analysis of translation control of Scl2 production by
the number of CAAAA pentanucleotide repeats with PhoZ reporter
constructs. (A) Schematic representation of the fusions between the
region of the scl2 gene encoding the Scl2 signal sequence
and phoZ (drawing not to scale). (Bottom) Plasmid pDC123
contains the phoZ gene under the control of the
tetM and cat tandem promoters. The signal
sequence (SS) and multiple cloning site (MCS) are located at the amino
terminus of the functional PhoZ protein. pDC123 was digested with
Eco47III and SphI restriction enzymes. (Middle)
Schematic of the GAS scl2 gene, including the promoter
(Pscl2) and regions encoding the signal sequence (SS),
variable region (V), collagen-like region (CL), and cell wall membrane
region (WM). A DNA fragment of scl2 containing the promoter
region and encoding the signal sequence of Scl2 was amplified by PCR,
digested with SmaI and SphI, and cloned into
pDC123. In the resulting construct, the secretion signal sequence of
PhoZ is replaced by the secretion signal sequence of Scl2; hence,
production of the full-length Scl2-PhoZ chimeric protein is dependent
on the presence of an in-frame number of CAAAA nucleotide repeats
located immediately downstream of the GTG start codon. (Top) Amino acid
sequences at the amino termini of the Scl2 signal sequences in two GAS
isolates and associated nucleotide sequences. Different numbers of
CAAAA nucleotide repeats located downstream of the GTG start codon are
shown. Four CAAAA repeats cause a frameshift in the downstream DNA
resulting in premature termination of translation in MGAS5005. In
contrast, three CAAAA repeats present in the scl2 gene from
MGAS6274 encode a functional signal sequence, resulting in Scl2
production. (B) Blue-white-colony phenotype depends on the number of
CAAAA pentanucleotide repeats. AP activity was detected in both
E. coli and GAS only when the phoZ reporter was
fused to the scl2 signal sequence with the correct
(in-frame) number of CAAAA repeats,
scl26274-phoZ.
|
|
 |
DISCUSSION |
The data presented in this paper and another very recent
contribution (20) indicate that GAS strains have two genes
that encode collagen-like proteins (Table
2). The Scl1 and Scl2 proteins have
several features in common with other GAS cell surface proteins (8), including a secretion signal sequence, variable
domain at the amino terminus of the mature protein, repetitive central part, and conserved cell wall membrane domain with an LPXTG cell wall
anchor motif. All 50 GAS strains tested, which together represent the
breadth of species diversity in GAS, have both the scl1 and scl2 genes. This finding differs from what was found for
emm and emm-like genes encoding streptococcal
cell surface proteins M and M-like, respectively. All GAS strains have
the emm gene encoding type-specific M protein, but other
emm family members (enn, fcrA, and
sph) are present only in some strains (5). The
emm and emm family genes are located contiguously
and their transcription is coordinately controlled by Mga. The two
scl genes are expressed in the exponential phase of growth;
however, the scl1 gene is regulated by Mga, whereas
scl2 is not. The scl1 and mga genes are located ~30 kb apart in the chromosome of an available serotype M1 GAS strain. At least one other gene controlled by Mga
(sof, encoding serum opacity factor) is located outside of
the region of the chromosome that contains mga and genes
immediately downstream of mga controlled by it
(23). Our study provides no insight into the molecular
mechanism controlling temporal regulation of scl2 gene
expression. However, Mga-independent but growth phase-dependent expression has been reported for the slo (streptolysin O)
and plr genes (22).
After this paper was submitted, Rasmussen et al. reported that the
scl1 gene was under Mga control in GAS strain AP1 (serotype M1) by using a transposon-inactivated mga mutant
(33).
Although we found that the scl2 gene was transcribed by all
six GAS strains tested in this study, not all of these organisms produced full-length Scl2 protein. Our data indicate that failure to produce Scl2 by some or all strains was due to premature
translation termination caused by variable numbers of CAAAA
pentanucleotide repeats located immediately downstream from the GTG
(Val) start codon. Analysis of the scl2 genes in four M28
serotype GAS strains with 3 to 16 CAAAA repeats predicted that only two
of these four strains should produce the full-length Scl2 protein.
Immunoblot and phoZ reporter fusion analyses fully supported
this prediction. Only the correct number of CAAAA repeats in a signal
sequence resulted in Scl2 protein production by GAS or in a blue-colony phenotype by phoZ fusion. In-frame expansion of the number
of CAAAA repeats would result in elongation of the signal sequence, a
process that could detrimentally affect Scl2 secretion. However, structural predictions made for the longest variant of the Scl2 signal
sequence (made by the allele with 17 CAAAA repeats) indicated that this
is not expected to be the case. Expansion of the CAAAA repeats would
result in production of additional QNKTK pentapeptides and extend the
charged domain of the secretion signal sequence. Of note, an
scl2 gene with 11 CAAAA repeats is present in MGAS6143 and
this strain secreted the Scl2 protein, a result indicating that
elongation of the charged domains of the secretion signal sequence is
not an impediment to extracellular production of Scl2.
Control of protein expression by variation in the number of SSRs such
as CAAAA has not been reported for GAS or other gram-positive bacteria.
There are several examples of genes whose expression is controlled by
SSRs in gram-negative bacteria. For example, variation in the number of
CAAT tetranucleotide repeats in lic1, lic2, and
lc3 regulates lipopolysaccharide production by
Haemophilus influenzae (42, 43). Cell surface
variation in Neisseria gonorrhoeae is caused by early
translation termination of the lsi-2 (lipopolysaccharide synthesis) and opa (opacity protein) genes and is due to
variation in the length of a polyguanidine tract and the number of
CTCTT repeats, respectively (6, 38). Phase and antigenic
variation in these microorganisms affects important biological traits
such as the ability of bacteria to colonize the host mucosal surface, to evade the host immune response, and to cause disease.
The frequency with which the number of CAAAA repeats varies in clonal
descendants of a GAS strain is unknown. Consequently, it is not known
if extracellular production of Scl2 undergoes classical, high-frequency
phase variation. However, the gene sequence data provide strong
indirect evidence that phase variation occurs (Table 1). Four of the
six serotype M12 strains (MGAS6139, MGAS6144, MGAS6198, and
MGAS6259) have scl2 genes that differ only by the number of CAAAA repeats. As a result, strains MGAS6139 (8 CAAAA repeats) and MGAS6144 (11 CAAAA repeats) are expected to express the
same mature Scl2 protein variant whereas translation of Scl2 by strains
MGAS6198 and MGAS6259 is expected to terminate prematurely (both
strains have 6 CAAAA repeats). These four strains have the same
multilocus enzyme electrophoretic type and multilocus gene sequence
type (unpublished data) and hence have a recent common ancestor.
Interestingly, these strains were isolated from patients in Texas
during an outbreak of invasive disease that occurred in the
winter of 1997 to 1998. Similarly, the scl2 genes in
serotype M28 strains MGAS6274 and MGAS6180 also differed only by the
number of CAAAA pentanucleotide repeats. As expected, MGAS6274 produces extracellular Scl whereas MGAS6180 does not because of premature translation termination (Fig. 5). These two strains also have a recent
common ancestor, as assessed by multilocus enzyme electrophoresis and
comparative sequencing of several other genes. Although these data are
limited, taken together they suggest that Scl2 extracellular production
can be modulated by cells that have recently descended from a common
ancestor. We speculate that phase variation of Scl2 extracellular
production in the course of pathogen-host interaction provides a
survival advantage or enhances durability. In this regard, we note that
variation in capsule production by Neisseria meningitidis is
due to 1-bp deletions and insertions occurring in contiguous cytosine
residues present in siaD (polysialyltransferase gene).
Insertion or deletion of one cytosine residue results in a frameshift
that produces premature translation termination or full-length
translation of this enzyme, which participates in capsule
synthesis (12). Spontaneous reversion of the
capsule-deficient variant occurred in vitro at the high frequency of
10
3. Similarly, size variation in several
variable-number-of-tandem-repeat loci has been reported among strains
of H. influenzae isolated from patients in an outbreak
of lung infections (41). Variation in the number of SSRs
is presumed to occur by slipped-strand mispairing during replication
(18), and there is evidence that amplification of the
number of SSRs by slipped-strand mispairing increases the likelihood of
subsequent slippage events. Hence, infrequent expansion of the CAAAA
present in scl2 might accelerate the frequency of insertions
and deletions. Therefore, it is possible that an scl2 allele
with 2 to 4 CAAAA repeats would be more stable than an scl2
allele with 8 to 10 CAAAA repeats. Additional experimental and
epidemiological studies are needed to fully understand molecular events
controlling production of Scl2 by GAS.
 |
ACKNOWLEDGMENTS |
We thank J. R. Scott and C. E. Rubens for providing
bacterial strains and plasmids.
This research was supported by Public Health Service grant AI-33119 to
J.M.M. and by funds from the Moran Foundation to S.L. We acknowledge a
streptococcal genome sequencing project funded by USPHS/NIH grant AI38406.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratory of
Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National
Institute of Allergy and Infectious Diseases, National Institutes of
Health, 903 South 4th St., Hamilton, MT 59840. Phone: (406) 363-9315. Fax: (406) 363-9427. E-mail: jmusser{at}niaid.nih.gov.
Present address: Department of Respiratory Diseases, Chubu National
Hospital, Aichi 474-8511, Japan.
Editor:
E. I. Tuomanen
 |
REFERENCES |
| 1.
|
Caparon, M. G., and J. R. Scott.
1987.
Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci.
Proc. Natl. Acad. Sci. USA
84:8677-8681[Abstract/Free Full Text].
|
| 2.
|
Chaffin, D. O., and C. E. Rubens.
1998.
Blue/white screening of recombinant plasmids in gram-positive bacteria by interruption of alkaline phosphatase gene (phoZ) expression.
Gene
219:91-99[CrossRef][Medline].
|
| 3.
|
Chen, C.,
N. Bormann, and P. P. Cleary.
1993.
VirR and Mry are homologous trans-acting regulators of M protein and C5a peptidase expression in group A streptococci.
Mol. Gen. Genet.
241:685-693[CrossRef][Medline].
|
| 4.
|
Courtney, H. S.,
H. C. Chiang,
J. L. Thacker, and J. B. Dale.
1999.
Serum opacity factor is a major fibronectin-binding protein and a virulence determinant of M type 2 Streptococcus pyogenes.
Mol. Microbiol.
32:89-98[CrossRef][Medline].
|
| 5.
|
Courtney, H. S.,
J. B. Dale, and D. L. Hasty.
2000.
Strategies for preventing group A streptococcal adhesion and infection, p. 553-579.
In
Y. H. An, and R. J. Friedman (ed.), Handbook of bacterial adhesion: principles, methods, and applications. Humana Press, Inc., Totowa, N.J.
|
| 6.
|
Danaher, R. J.,
J. C. Levin,
D. Arking,
C. L. Burch,
R. Sandlin, and D. C. Stein.
1995.
Genetic basis of Neisseria gonorrhoeae lipooligosaccharide antigenic variation.
J. Bacteriol.
177:7275-7279[Abstract/Free Full Text].
|
| 7.
|
Fischetti, V. A.
1989.
Streptococcal M protein: molecular design and biological behavior.
Clin. Microbiol. Rev.
2:285-314[Abstract/Free Full Text].
|
| 8.
|
Fischetti, V. A.
2000.
Surface proteins on gram-positive bacteria, p. 11-24.
In
V. A. Fischetti, R. P. Novick, J. J. Ferretti, D. A. Portnoy, and J. I. Rood (ed.), Gram-positive pathogens. American Society for Microbiology, Washington, D.C.
|
| 9.
|
Fogg, G. C.,
C. M. Gibson, and M. G. Caparon.
1994.
The identification of rofA, a positive-acting regulatory component of prtF expression: use of an m -based shuttle mutagenesis strategy in Streptococcus pyogenes.
Mol. Microbiol.
11:671-684[CrossRef][Medline].
|
| 10.
|
Garnier, J.,
D. J. Osguthorpe, and B. Robson.
1978.
Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.
J. Mol. Biol.
120:97-120[CrossRef][Medline].
|
| 11.
|
Gold, L.,
D. Pribnow,
T. Schneider,
S. Shinedling,
B. W. Singer, and G. Stormo.
1981.
Translational initiation in prokaryotes.
Annu. Rev. Microbiol.
35:365-403[CrossRef][Medline].
|
| 12.
|
Hammerschmidt, S.,
A. Muller,
H. Sillmann,
M. Muhlenhoff,
R. Borrow,
A. Fox,
J. van Puten,
W. D. Zollinger,
R. Gerardy-Schahn, and M. Frosch.
1996.
Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease.
Mol. Microbiol.
20:1211-1220[Medline].
|
| 13.
|
Hanski, E., and M. Caparon.
1992.
Protein F, a fibronectin-binding protein, is an adhesin of the group A streptococcus Streptococcus pyogenes.
Proc. Natl. Acad. Sci. USA
89:6172-6176[Abstract/Free Full Text].
|
| 14.
|
Heath, D. G., and P. P. Cleary.
1989.
Fc-receptor and M-protein genes of group A streptococci are products of gene duplication.
Proc. Natl. Acad. Sci. USA
86:4741-4745[Abstract/Free Full Text].
|
| 15.
|
Kyte, J., and R. F. Doolittle.
1982.
A simple method for displaying the hydropathic character of a protein.
J. Mol. Biol.
157:105-132[CrossRef][Medline].
|
| 16.
|
Lee, M. H.,
A. Nittayajarn,
R. P. Ross,
C. B. Rothschild,
D. Parsonage,
A. Claiborne, and C. E. Rubens.
1999.
Characterization of Enterococcus faecalis alkaline phosphatase and use in identifying Streptococcus agalactiae secreted proteins.
J. Bacteriol.
181:5790-5799[Abstract/Free Full Text].
|
| 17.
|
Levin, J. C., and M. R. Wessels.
1998.
Identification of csrRlcsrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus.
Mol. Microbiol.
30:209-219[CrossRef][Medline].
|
| 18.
|
Levinson, G., and G. A. Gutman.
1987.
Slipped-strand mispairing: a major mechanism for DNA sequence evolution.
Mol. Biol. Evol.
4:203-221[Abstract].
|
| 19.
|
Lukomski, S.,
N. P. Hoe,
I. Abdi,
J. Rurangirwa,
P. Kordari,
M. Liu,
D. Shu-Jun,
G. G. Adams, and J. M. Musser.
2000.
Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization.
Infect. Immun.
68:535-542[Abstract/Free Full Text].
|
| 20.
|
Lukomski, S.,
K. Nakashima,
I. Abdi,
V. J. Cipriano,
R. M. Ireland,
S. R. Reid,
G. G. Adams, and J. M. Musser.
2000.
Identification and characterization of the scl gene encoding a group A Streptococcus extracellular protein virulence factor with similarity to human collagen.
Infect. Immun.
68:6542-6553[Abstract/Free Full Text].
|
| 21.
|
Lyon, W. R.,
C. M. Gibson, and M. G. Caparon.
1998.
A role for trigger factor and an Rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes.
EMBO J.
17:6263-6275[CrossRef][Medline].
|
| 22.
|
McIver, K. S., and J. R. Scott.
1997.
Role of mga in growth phase regulation of virulence genes of the group A Streptococcus.
J. Bacteriol.
179:5178-5187[Abstract/Free Full Text].
|
| 23.
|
McLandsborough, L. A., and P. P. Cleary.
1995.
Insertional inactivation of virR in Streptococcus pyogenes M49 demonstrates that VirR functions as a positive regulator of ScpA, FcRA, OF, and M protein.
FEMS Microbiol. Lett.
128:45-51[CrossRef][Medline].
|
| 24.
|
Musser, J. M.,
A. R. Hauser,
M. H. Kim,
P. M. Schlievert,
K. Nelson, and R. K. Selander.
1991.
Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression.
Proc. Natl. Acad. Sci. USA
88:2668-2672[Abstract/Free Full Text].
|
| 25.
|
Musser, J. M.,
V. Kapur,
J. Szeto,
X. Pan,
D. S. Swanson, and D. R. Martin.
1995.
Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease.
Infect. Immun.
63:994-1003[Abstract].
|
| 26.
|
Patti, J. M.,
B. L. Allen,
M. J. McGavin, and M. Hook.
1994.
MSCRAMM-mediated adherence of microorganisms to host tissues.
Annu. Rev. Microbiol.
48:585-617[Medline].
|
| 27.
|
Perez-Casal, J.,
M. G. Caparon, and J. R. Scott.
1991.
Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems.
J. Bacteriol.
173:2617-2624[Abstract/Free Full Text].
|
| 28.
|
Perez-Casal, J. F.,
H. F. Dillon,
L. K. Husmann,
B. Graham, and J. R. Scott.
1993.
Virulence of two Streptococcus pyogenes strains (types M1 and M3) associated with toxic-shock-like syndrome depends on an intact mry-like gene.
Infect. Immun.
61:5426-5430[Abstract/Free Full Text].
|
| 29.
|
Perlman, D., and H. O. Halvorson.
1983.
A putative signal recognition site and sequence in eukaryotic and prokaryotic signal peptides.
J. Mol. Biol.
167:391-409[CrossRef][Medline].
|
| 30.
|
Podbielski, A.,
A. Flosdorff, and J. Weber-Heynemann.
1995.
The group A streptococcal virR49 gene controls expression of four structural vir regulon genes.
Infect. Immun.
63:9-20[Abstract].
|
| 31.
|
Podbielski, A.,
M. Woischnik,
B. A. B. Leonard, and K.-H. Schmidt.
1999.
Characterization of nra, a global negative regulator gene in group A streptococci.
Mol. Microbiol.
31:1051-1064[CrossRef][Medline].
|
| 32.
|
Podbielski, A.,
M. Woischnik,
B. Pohl, and K. H. Schmidt.
1996.
What is the size of the group A streptococcal vir regulon? The Mga regulator affects expression of secreted and surface factors.
Med. Microbiol. Immunol.
185:171-181[CrossRef][Medline].
|
| 33.
|
Rasmussen, M.,
A. Eden, and L. Bjorck.
2000.
SclA, a novel collagen-like surface protein of Streptococcus pyogenes.
Infect. Immun.
68:6370-6377[Abstract/Free Full Text].
|
| 34.
|
Rasmussen, M.,
H.-P. Muller, and L. Bjorck.
1999.
Protein GRAB of Streptococcus pyogenes regulates proteolysis at bacterial surface by binding 2-macroglobulin.
J. Biol. Chem.
274:15336-15344[Abstract/Free Full Text].
|
| 35.
|
Rosenberg, D. E., and D. Court.
1979.
Regulatory sequences involved in the promotion and termination of RNA transcription.
Annu. Rev. Genet.
13:319-353[CrossRef][Medline].
|
| 36.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Plainview, N.Y.
|
| 37.
|
Shine, J., and L. Dalgarno.
1974.
The 3'-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites.
Proc. Natl. Acad. Sci. USA
71:1342-1346[Abstract/Free Full Text].
|
| 38.
|
Stern, A.,
M. Brown,
P. Nickel, and T. F. Meyer.
1986.
Opacity genes in Neisseria gonorrhoeae: control of phase and antigenic variation.
Cell
47:61-71[CrossRef][Medline].
|
| 39.
|
Stevens, D. L.
1992.
Invasive group A Streptococcus infections.
Clin. Infect. Dis.
14:2-13[Medline].
|
| 40.
|
van Belkum, A.,
S. Scherer,
L. van Alphen, and H. Verbrugh.
1998.
Short-sequence DNA repeats in prokaryotic genomes.
Microbiol. Mol. Biol. Rev.
62:275-293[Abstract/Free Full Text].
|
| 41.
|
van Belkum, A.,
S. Scherer,
W. van Leeuwen,
D. Willemse,
L. van Alphen, and H. Verbrugh.
1997.
Variable number of tandem repeats in clinical strains of Haemophilus influenzae.
Infect. Immun.
65:5017-5027[Abstract].
|
| 42.
|
Weiser, J. N.,
J. M. Love, and E. R. Moxon.
1989.
The molecular mechanism of phase variation of H. influenzae lipopolysaccharide.
Cell
59:657-665[CrossRef][Medline].
|
| 43.
|
Weiser, J. N.,
D. J. Maskell,
P. D. Butler,
A. A. Lindberg, and E. R. Moxon.
1990.
Characterization of repetitive sequences controlling phase variation of Haemophilus influenzae lipopolysaccharide.
J. Bacteriol.
172:3304-3309[Abstract/Free Full Text].
|
| 44.
|
Wexler, D. E.,
D. E. Chenoweth, and P. P. Cleary.
1985.
Mechanism of action of the group A streptococcal C5a inactivator.
Proc. Natl. Acad. Sci. USA
82:8144-8148[Abstract/Free Full Text].
|
Infection and Immunity, March 2001, p. 1729-1738, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1729-1738.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Caswell, C. C., Barczyk, M., Keene, D. R., Lukomska, E., Gullberg, D. E., Lukomski, S.
(2008). Identification of the First Prokaryotic Collagen Sequence Motif That Mediates Binding to Human Collagen Receptors, Integrins {alpha}2{beta}1 and {alpha}11{beta}1. J. Biol. Chem.
283: 36168-36175
[Abstract]
[Full Text]
-
Oliva, C. R., Swiecki, M. K., Griguer, C. E., Lisanby, M. W., Bullard, D. C., Turnbough, C. L. Jr., Kearney, J. F.
(2008). The integrin Mac-1 (CR3) mediates internalization and directs Bacillus anthracis spores into professional phagocytes. Proc. Natl. Acad. Sci. USA
105: 1261-1266
[Abstract]
[Full Text]
-
Mohs, A., Silva, T., Yoshida, T., Amin, R., Lukomski, S., Inouye, M., Brodsky, B.
(2007). Mechanism of Stabilization of a Bacterial Collagen Triple Helix in the Absence of Hydroxyproline. J. Biol. Chem.
282: 29757-29765
[Abstract]
[Full Text]
-
Pahlman, L. I., Marx, P. F., Morgelin, M., Lukomski, S., Meijers, J. C. M., Herwald, H.
(2007). Thrombin-activatable Fibrinolysis Inhibitor Binds to Streptococcus pyogenes by Interacting with Collagen-like Proteins A and B. J. Biol. Chem.
282: 24873-24881
[Abstract]
[Full Text]
-
Zhang, S., Green, N. M., Sitkiewicz, I., LeFebvre, R. B., Musser, J. M.
(2006). Identification and Characterization of an Antigen I/II Family Protein Produced by Group A Streptococcus. Infect. Immun.
74: 4200-4213
[Abstract]
[Full Text]
-
Humtsoe, J. O., Kim, J. K., Xu, Y., Keene, D. R., Hook, M., Lukomski, S., Wary, K. K.
(2005). A Streptococcal Collagen-like Protein Interacts with the {alpha}2{beta}1 Integrin and Induces Intracellular Signaling. J. Biol. Chem.
280: 13848-13857
[Abstract]
[Full Text]
-
Almengor, A. C., McIver, K. S.
(2004). Transcriptional Activation of sclA by Mga Requires a Distal Binding Site in Streptococcus pyogenes. J. Bacteriol.
186: 7847-7857
[Abstract]
[Full Text]
-
Beres, S. B., Sylva, G. L., Sturdevant, D. E., Granville, C. N., Liu, M., Ricklefs, S. M., Whitney, A. R., Parkins, L. D., Hoe, N. P., Adams, G. J., Low, D. E., DeLeo, F. R., McGeer, A., Musser, J. M.
(2004). Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc. Natl. Acad. Sci. USA
101: 11833-11838
[Abstract]
[Full Text]
-
van Selm, S., van Cann, L. M., Kolkman, M. A. B., van der Zeijst, B. A. M., van Putten, J. P. M.
(2003). Genetic Basis for the Structural Difference between Streptococcus pneumoniae Serotype 15B and 15C Capsular Polysaccharides. Infect. Immun.
71: 6192-6198
[Abstract]
[Full Text]
-
Rasmussen, M., Jacobsson, M., Bjorck, L.
(2003). Genome-based Identification and Analysis of Collagen-related Structural Motifs in Bacterial and Viral Proteins. J. Biol. Chem.
278: 32313-32316
[Abstract]
[Full Text]
-
Ariel, N., Zvi, A., Makarova, K. S., Chitlaru, T., Elhanany, E., Velan, B., Cohen, S., Friedlander, A. M., Shafferman, A.
(2003). Genome-Based Bioinformatic Selection of Chromosomal Bacillus anthracis Putative Vaccine Candidates Coupled with Proteomic Identification of Surface-Associated Antigens. Infect. Immun.
71: 4563-4579
[Abstract]
[Full Text]
-
Sylvestre, P., Couture-Tosi, E., Mock, M.
(2003). Polymorphism in the Collagen-Like Region of the Bacillus anthracis BclA Protein Leads to Variation in Exosporium Filament Length. J. Bacteriol.
185: 1555-1563
[Abstract]
[Full Text]
-
Reid, S. D., Green, N. M., Sylva, G. L., Voyich, J. M., Stenseth, E. T., DeLeo, F. R., Palzkill, T., Low, D. E., Hill, H. R., Musser, J. M.
(2002). Postgenomic Analysis of Four Novel Antigens of Group A Streptococcus: Growth Phase-Dependent Gene Transcription and Human Serologic Response. J. Bacteriol.
184: 6316-6324
[Abstract]
[Full Text]
-
Areschoug, T., Linse, S., Stalhammar-Carlemalm, M., Heden, L.-O., Lindahl, G.
(2002). A Proline-Rich Region with a Highly Periodic Sequence in Streptococcal {beta} Protein Adopts the Polyproline II Structure and Is Exposed on the Bacterial Surface. J. Bacteriol.
184: 6376-6383
[Abstract]
[Full Text]
-
Pericone, C. D., Bae, D., Shchepetov, M., McCool, T., Weiser, J. N.
(2002). Short-Sequence Tandem and Nontandem DNA Repeats and Endogenous Hydrogen Peroxide Production Contribute to Genetic Instability of Streptococcus pneumoniae. J. Bacteriol.
184: 4392-4399
[Abstract]
[Full Text]
-
Xu, Y., Keene, D. R., Bujnicki, J. M., Hook, M., Lukomski, S.
(2002). Streptococcal Scl1 and Scl2 Proteins Form Collagen-like Triple Helices. J. Biol. Chem.
277: 27312-27318
[Abstract]
[Full Text]
-
Smoot, J. C., Korgenski, E. K., Daly, J. A., Veasy, L. G., Musser, J. M.
(2002). Molecular Analysis of Group A Streptococcus Type emm18 Isolates Temporally Associated with Acute Rheumatic Fever Outbreaks in Salt Lake City, Utah. J. Clin. Microbiol.
40: 1805-1810
[Abstract]
[Full Text]
-
Kreikemeyer, B., Beckert, S., Braun-Kiewnick, A., Podbielski, A.
(2002). Group A streptococcal RofA-type global regulators exhibit a strain-specific genomic presence and regulation pattern. Microbiology
148: 1501-1511
[Abstract]
[Full Text]
-
Barnett, T. C., Scott, J. R.
(2002). Differential Recognition of Surface Proteins in Streptococcus pyogenes by Two Sortase Gene Homologs. J. Bacteriol.
184: 2181-2191
[Abstract]
[Full Text]
-
Reid, S. D., Green, N. M., Buss, J. K., Lei, B., Musser, J. M.
(2001). Multilocus analysis of extracellular putative virulence proteins made by group A Streptococcus: Population genetics, human serologic response, and gene transcription. Proc. Natl. Acad. Sci. USA
98: 7552-7557
[Abstract]
[Full Text]
-
Janulczyk, R., Rasmussen, M.
(2001). Improved Pattern for Genome-Based Screening Identifies Novel Cell Wall-Attached Proteins in Gram-Positive Bacteria. Infect. Immun.
69: 4019-4026
[Abstract]
[Full Text]